Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2009
DOI: 10.1002/ppul.21128
|View full text |Cite
|
Sign up to set email alerts
|

Cyanosis revealing hepatopulmonary syndrome in a child with dyskeratosis congenita

Abstract: We report the case of a 5-year-old child with dyskeratosis congenita who presented cyanosis and dyspnea at exertion. He had severe hypoxemia with elevated alveolar-arterial oxygen gradient in the setting of liver disease. Technetium-99m-labeled macroaggregated albumin scan showed abnormally high uptake in the brain, confirming hepatopulmonary syndrome.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(13 citation statements)
references
References 12 publications
0
7
0
Order By: Relevance
“…Th e isolated reports of children with dyskeratosis congenita in whom dyspnea was a prominent presenting symptom of liver disease suggest a specifi c association of HPS with telomere dysfunction. 13,[26][27][28][29][30][31][32] Although our experience suggests HPS is a common presentation of liver disease in patients with short telomere syndrome, it is possible that there are alternate presentations of hepatic pathology, including overt cryptogenic cirrhosis. Regardless, recognizing the short telomere syndrome diagnosis is important for management, especially in the transplant setting where these patients have increased rates of acute complications related to myelosuppressive and other medications.…”
Section: Discussionmentioning
confidence: 82%
“…Th e isolated reports of children with dyskeratosis congenita in whom dyspnea was a prominent presenting symptom of liver disease suggest a specifi c association of HPS with telomere dysfunction. 13,[26][27][28][29][30][31][32] Although our experience suggests HPS is a common presentation of liver disease in patients with short telomere syndrome, it is possible that there are alternate presentations of hepatic pathology, including overt cryptogenic cirrhosis. Regardless, recognizing the short telomere syndrome diagnosis is important for management, especially in the transplant setting where these patients have increased rates of acute complications related to myelosuppressive and other medications.…”
Section: Discussionmentioning
confidence: 82%
“…While HPS is a well‐recognized, albeit rare, complication of any form of liver disease, it appears to be relatively common in DC patients with either cirrhosis or NRH . This association of HPS and short telomere syndromes may suggest some mechanistic overlap.…”
Section: Discussionmentioning
confidence: 99%
“…Finally, a child with a mutation in TINF2 gene who underwent a BMT aged 4 years developed severe HPS by the age of 5. No liver biopsy was performed, and the patient was listed for liver transplantation at the time of publication …”
Section: Discussionmentioning
confidence: 99%
“…Most information comes from single case reports or small case series. Non-cirrhotic portal hypertension (104106) and hepatopulmonary syndrome (107) have been reported in individuals with DC. Similar to IPF, liver disease may be the presenting clinical manifestation of a telomere biology disorder.…”
Section: Liver Diseasementioning
confidence: 99%